2023-505297-15-00招募中1 期
A study to investigate the effects of multiple doses of obefazimod on a combined oral contraceptive (ethinyl estradiol/drospirenone) in healthy female participants of childbearing potential.
Abivax, Abivax1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2023年8月9日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 36
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Operations
Scientific
Abivax
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Phase 1 Randomized Study to Evaluate the Effect of Food on the Bioavailability of BMS-986158 in Participants with Advanced Solid Tumors.2023-506661-65-00Bristol-Myers Squibb Services Unlimited Company40
已完成
不适用
Safety and clinical effects of IDX320 in Hepatitis C infectioGenotype 1 Chronic Hepatitis CInfections and InfestationsChronic viral hepatitisISRCTN44746369Idenix Pharmaceuticals (USA)88
进行中（未招募）
1 期
A first-in-human trial of IDX21437, a new study drug being evaluated for hepatitis C virus infection.Hepatitis C virusMedDRA version: 16.1Level: LLTClassification code 10019751Term: Hepatitis C virusSystem Organ Class: 100000004848EUCTR2013-004043-23-BEIdenix Pharmaceuticals Inc.
进行中（未招募）
不适用
A Phase I/IIa Study Assessing Single and Multiple Doses of HCV Protease Inhibitor IDX320 in Healthy and Genotype 1 HCV-Infected SubjectsHealthy Volunteers and Genotype 1 HCV infectionMedDRA version: 12.1Level: LLTClassification code 10008912Term: Chronic hepatitis CEUCTR2009-018079-15-HUIdenix Pharmaceuticals, Inc84
进行中（未招募）
不适用
A Phase I/IIa Study Assessing Single and Multiple Doses of HCV Protease Inhibitor IDX320 in Healthy and Genotype 1 HCV-Infected SubjectsEUCTR2009-018079-15-PLIdenix Pharmaceuticals, Inc.88